MSH2 and digestive system neoplasm: Although it needs to be confirmed by larger collaboration studies, the low incidence of extra-GI neoplasms in the spectrum of EPCAM LS tumors could be, in part, explained by the mechanism of epigenetic MSH2 silencing.